Skip to main content
. 2018 Feb 13;118(6):785–792. doi: 10.1038/bjc.2017.489

Figure 2.

Figure 2

Kaplan–Meier estimates of OSBRAFi calculated from the beginning of BRAFi therapy. Overall survival (OSBRAFi) was calculated from start of BRAFi therapy and was analysed for patients with concomitant and interrupted BRAFi treatment during radiotherapy (A) and separately for the subgroups treated with vemurafenib and dabrafenib (B). BRAFi=BRAF inhibitor; RT=radiotherapy.